Reagent is required to perform allergy testing which provides healthcare providers with critical information in the detection/management of allergic reactions for the SAN antonio market and 153…
Ended Awarded
- Contract number
- HT009025FG0830105
- Awardee
-
Phadia US Inc. UEI DK4EVCWUNUM4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $49,922
Award facts
- Contract value 100% obligated
- $49,921.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Portage, MI 49002, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a Blanket Purchase Agreement call valued at $49,921.55 to Phadia US Inc.'s Immunodiagnostics Division on July 23, 2025, with completion targeted for September 30, 2025. Under this firm fixed-price contract, Phadia will supply allergy testing reagents to support healthcare providers across the San Antonio military treatment facility and 153 additional military medical installations. The reagents are essential for detecting and managing allergic reactions across the Military Health System. This award was not designated as a set-aside procurement and represents an open market purchase.
Phadia US Inc., a foreign-owned subsidiary of Thermo Fisher Scientific, serves as a critical provider of immunodiagnostic solutions to federal defense and healthcare agencies. The company specializes in advanced allergy and autoimmune testing equipment and supplies, with a established track record of supporting military medical facilities through the Defense Health Agency and Army Medical Command. Performance will be conducted at the vendor's facility in Portage, Michigan. This contract call draws from Phadia's broader relationship with the military medical enterprise, complementing the company's existing Indefinite Delivery/Indefinite Quantity agreements valued at $13.8 million each with Air Force Air Education and Training Command for IMMUNOCAP system analyzers and associated diagnostic equipment.
Description
Reagent is required to perform allergy testing which provides healthcare providers with critical information in the detection/management of allergic reactions for the SAN antonio market and 153 other military treatment facilities.
Quick answers
Who was awarded contract HT009025FG0830105?
HT009025FG0830105 was awarded to Phadia US Inc. by Defense Health Agency (Department of Defense) on July 23, 2025.
How much is contract HT009025FG0830105 worth?
The government has obligated $49,922 on HT009025FG0830105.
Is contract HT009025FG0830105 an order under another contract?
Yes. HT009025FG0830105 is a BPA call under FA301624A0046, a blanket purchase agreement.
Was contract HT009025FG0830105 competed?
The extent of competition for HT009025FG0830105 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award